Cargando…

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients

BACKGROUND: Circulating adipocyte fatty acid-binding protein (FABP4) levels are considered to be a link between obesity, insulin resistance, diabetes, and cardiovascular (CV) diseases. In vitro, FABP4 has exhibited cardiodepressant activity by suppressing cardiomyocyte contraction. We have explored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabré, Anna, Valdovinos, Pilar, Lázaro, Iolanda, Bonet, Gil, Bardají, Alfredo, Masana, Lluís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653725/ https://www.ncbi.nlm.nih.gov/pubmed/23642261 http://dx.doi.org/10.1186/1475-2840-12-72

Ejemplares similares

Level of FABP3, FABP4, Nt-proBNP and Total Cardiovascular Risk in the Population of Central Kazakhstan
por: Marchenko, Alexandr Borisovich, et al.
Publicado: (2017)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

NT-proBNP Levels and Collateral Circulation Status in Patients with Acute Ischemic Stroke
por: Shen, Xiaozhu, et al.
Publicado: (2023)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy
por: Koura, Hala Mahmoud, et al.
Publicado: (2016)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
por: Legrand, Lise, et al.
Publicado: (2020)

Prognostic value of NT-proBNP in patients with severe COVID-19
por: Gao, Lei, et al.
Publicado: (2020)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
por: Lau, Chin-Shern, et al.
Publicado: (2022)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
por: António, Maria, et al.
Publicado: (2023)

Serum A-FABP Is Increased and Closely Associated with Elevated NT-proBNP Levels in Type 2 Diabetic Patients Treated with Rosiglitazone
por: Zhou, Mi, et al.
Publicado: (2011)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
por: Welsh, Paul, et al.
Publicado: (2022)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

NT-proBNP levels in the ICU do not predict the etiology of respiratory distress
por: Mailloux, P, et al.
Publicado: (2006)

NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure
por: Foo, Jared Yong Yang, et al.
Publicado: (2012)

NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014)

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients
por: Ducros, Jacques, et al.
Publicado: (2017)

NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure
por: Pan, Yesheng, et al.
Publicado: (2017)

Preoperative NT‐proBNP Predicts Midterm Outcome After Septal Myectomy
por: Song, Changpeng, et al.
Publicado: (2019)

Usefulness of NT-proBNP in the Follow-Up of Patients after Myocardial Infarction
por: Radosavljevic-Radovanovic, Mina, et al.
Publicado: (2016)

NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome
por: Gehle, Petra, et al.
Publicado: (2016)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic Sclerosis
por: MURESAN, Lucian, et al.
Publicado: (2017)

NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis
por: Nguyen, Vi, et al.
Publicado: (2013)

Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications
por: Birukov, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2nar7kir2g1e6lk26hb7olgsr4